Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
Tenosynovial giant cell tumor (TGCT) is challenging to diagnose and manage, requiring the coordination of clinicians across specialties. In this BURST CME™ activity, 2 experts in TGCT management review the current landscape of diagnosis and treatment, including discussion of the strengths and limitations of established diagnostic approaches and an exploration of the expanding therapeutic arsenal for this disease. Multidisciplinary management of TGCT is also discussed to integrate surgical, systemic, supportive, and rehabilitative care for patients.
Target Audience
This educational program is directed toward medical oncologists, orthopedic surgeons, orthopedic oncologists, radiologists, pathologists, advanced practice providers, general practitioners, nuclear medicine physicians, and other health care professionals involved in the treatment of TGCT.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify patients with tenosynovial giant cell tumor (TGCT) through early symptom recognition and optimal application of established diagnostic approaches
- Assess the potential clinical implications of recent data and ongoing trials of approved and emerging therapies when personalizing treatment in patients with TGCT
- Select optimal therapy according to available data, disease subtype, extent of recurrence, and other factors in patients with TGCT
- Evaluate the role of multidisciplinary strategies in advancing the management of patients with TGCT
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here